MRNA - Moderna, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 51.81B
Enterprise value 43.11B
Trailing P/E 6.47
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.87
Price/book (mrq)2.62
Enterprise value/revenue 2.91
Enterprise value/EBITDA 8.06

Trading information

Stock price history

Beta (5Y monthly) 1.69
52-week change 3-8.90%
S&P500 52-week change 30.07%
52-week high 3217.25
52-week low 3115.03
50-day moving average 3139.99
200-day moving average 3154.18

Share statistics

Avg vol (3-month) 33.42M
Avg vol (10-day) 33.73M
Shares outstanding 5381.21M
Implied shares outstanding 6N/A
Float 8344.03M
% held by insiders 19.61%
% held by institutions 168.33%
Shares short (14 May 2023) 418.22M
Short ratio (14 May 2023) 45.02
Short % of float (14 May 2023) 46.36%
Short % of shares outstanding (14 May 2023) 44.78%
Shares short (prior month 13 Apr 2023) 416.7M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 31.77%
Operating margin (ttm)32.05%

Management effectiveness

Return on assets (ttm)11.66%
Return on equity (ttm)26.62%

Income statement

Revenue (ttm)15.06B
Revenue per share (ttm)38.61
Quarterly revenue growth (yoy)-69.30%
Gross profit (ttm)10.55B
Net income avi to common (ttm)4.78B
Diluted EPS (ttm)11.95
Quarterly earnings growth (yoy)-97.80%

Balance sheet

Total cash (mrq)8.92B
Total cash per share (mrq)23.41
Total debt (mrq)1.11B
Total debt/equity (mrq)5.87
Current ratio (mrq)3.46
Book value per share (mrq)49.12

Cash flow statement

Operating cash flow (ttm)993M
Levered free cash flow (ttm)541.88M